Genetic, clinical, and neuropathologic heterogeneity have been observed in frontotemporal lobar degeneration with ubiquitin (Ubq)-positive inclusions (FTLD-U) and FTLD-U with motor neuron disease. Here, the distribution and morphologic features of neuronal and glial inclusions in the brains of 20 FTLD-U and 2 FTLD-U/ motor neuron disease cases were assessed using immunohistochemistry for Ubq-binding protein p62. Eighteen cases displayed TAR DNA-binding protein 43Yimmunoreactive lesions and were classified as Types 3 (neuronal cytoplasmic inclusions and neurites; 72%), 2 (primarily neuronal cytoplasmic inclusions; 17%), or 1 (primarily neurites; 11%) FTLD-U. The distribution of p62-immunoreactivity varied considerably in each type. Of 4 unclassifiable cases, 2 displayed p62-immunoreactive lesions suggestive of FTLD-U with a mutation in the charged multivesicular body protein 2B gene; 1 suggested basophilic inclusion body disease, and 1 was of a type not previously described. By immunohistochemistry for Ubq-binding protein p62, the distribution of abnormalities was wider than expected; in approximately half of the cases, there were p62-positive but TAR DNA-binding protein 43-negative inclusions in the cerebellum, a region not previously considered to be affected. In other regions, TAR DNA-binding protein 43-, Ubq-, and Ubqbinding protein p62 labeling of inclusions was variable. Whether variations in inclusion morphologies, immunoreactivity, and topographic distribution are due to methodologic factors, different stages of inclusion and disease evolution, different disease entities or biologic modifications of the same disease are presently unclear.
INTRODUCTION
In 1988, Lowe et al (1) described ubiquitin (Ubq)-only labeled inclusions in motor neuron disease (MND). Subsequently, in 1996, Jackson et al (2) described the same inclusions in subjects with progressive frontotemporal dementia (FTD). Attempts toward both clinical and pathologic classification schemes for these cases were made in the next years (3, 4) . They are now recognized as a subgroup of the recently well-recognized clinical entity of FTD that accounts for approximately 10% to 20% of all dementia cases (5, 6) . Approximately 35% to 50% of FTD cases display a familial history of dementia (7) . The clinical features of FTD are heterogeneous because patients may exhibit both early and progressive manifestations, particularly changes in behavior or personality and language dysfunctions (7, 8) . The clinical entity FTD is defined neuropathologically as frontotemporal lobar degeneration (FTLD) to emphasize the dominant distributional pattern of lesions (8, 9) . This frontotemporal distribution of pathoanatomic abnormalities had previously been described by Gustafson et al (10) in 1977.
Neuropathologic findings, that is, immunoreactive (IR) structures, currently define the recognized 3 major subgroups of FTLD (7, 8) . One is represented by an accumulation of insoluble aggregates of microtubule-associated hyperphosphorylated-T protein (HPT). In some of these cases, a mutation in the gene encoding HPT on chromosome 17 has been reported (11) . Half of the FTLD cases lack both HPTand >-synuclein (>S)-IR inclusions (12Y19) but have ubiquitinated lesions and are therefore known as BFTLD with Ubq-only pathology[ (FTLD-U). In some familial FTLD-U cases, mutations in the progranulin gene have been reported (20, 21) . In 2006, TAR-DNA-binding protein 43 (TDP-43), a highly concentrated nuclear factor of yet unclear function (22Y24), was identified as a major component of Ubq-IR lesions (25, 26) . Recently, the term BTDP-43 proteinopathy[ has been applied to these cases (25, 27Y32) . Some FTLD-U cases display motor neuron damage and were named by Lowe et al (1) as MND-inclusion dementia cases. This entity was later designated as FTD-MND (33, 34) , and currently, the term FTLD-U/MND is recommended (8) . In rare FTLD-U cases, Ubq-IR lesions have also been found to be IR for >-internexin; thus, these cases have been termed neuronal intermediate filament inclusion body disease (35) . In addition, there still remains a small group of FTLD cases that lack IR pathology as detected by currently used antibodies, and these cases are referred to as Bdementia lacking distinctive histopathology.[ In 1998, when establishing a pathologic diagnosis in the degenerative dementias, Lowe (36) recommended that Ubq-IR lesions should be assessed in the dentate granule cells and in the layer II neurons of the frontal and temporal cortices. Therefore, many of the studies of FTLD (37Y45), with one exception (46) , have focused on the assessment of Ubq-IR pathology in a few or even 1 single anatomic region. At present, there are no systematic assessments of the regional distribution of these abnormalities.
The first systematic histopathologic classifications of FTLD-U cases were based on the distribution and type of Ubq-IR lesions, that is, neuronal cytoplasmic inclusions (NCIs), neuronal nuclear inclusions (NNIs), and neurites in the frontal and temporal cortices and in the granule cell layer of the dentate gyrus in the hippocampal formation ( Fig. 1 ) (42, 45) . Subsequently, these histopathologic classifications have been successfully applied to categorize FTLD-U cases using TDP-43-IHC (27, 28) . It is noteworthy that, in addition to the 3 original histopathologic types characterized by Sampathu et al (45) , a fourth type was described by Cairns et al ( Fig. 1) (28) . When assessing in detail 193 FTLD-U cases, Cairns et al (28) stated that despite significant clinical, genetic, and neuropathologic heterogeneity, TDP-43 was a common pathologic substrate because it was detected in most (i.e. 189 subjects) of their cases. They noted that all subjects with the progranulin mutation were of 1 histopathologic type (i.e. Type 3), but only 38% of subjects with histologic Type 3 carried a mutation on their progranulin gene. Furthermore, with respect to clinical manifestations, 52% of their 21 sporadic FTD/MND cases displayed the histopathology of Type 3, 38% of Type 2, and 10% of Type 1. To date, with 1 exception, no strict association between the currently recognized histopathologic subtypes, genetic, and/or clinical presentation has been found. The 1 exception is the histopathologic Type 4, where all 5 subjects had the valosincontaining protein mutation, and all displayed a clinical FTD phenotype (28) .
Since 2007, TDP-43-IHC has been recommended for assessing FTLD-U cases because this protein is considered to be disease-specific (28, 29) . TAR-DNA-binding protein 43 is FIGURE 1. The flowchart delineates the logistics of this study. (A) Immunoreactive lesions seen in aged unimpaired subjects were assessed when using ubiquitin, p62, and TAR-DNA-binding protein 43 (TDP-43) immunohistochemistry in 5 age-matched neurologically unimpaired subjects. (B) Selection criteria for the 22 selected cognitively impaired subjects, and anatomic brain regions stained using hematoxylin and eosin to observe possible lower motor neuron involvement and hyperphosphorylated-TY, A-amyloid-, and >-synuclein-immunohistochemistry methods to assess concomitant pathologies. (C) The current histologic classification schemes of frontotemporal lobar degeneration with ubiquitin-only pathology subjects: the histologic schemes by Mackenzie et al (42) and by Sampathu et al (45) are based on ubiquitin (Ubq)-immunoreactive (IR) pathologies, whereas the third scheme proposed by Cairns et al (28) is based on Ubq-and TDP-43-immunoreactive pathologies. (D) Assessment of regional distribution of p62-IR lesions. FTLD-U/MND, frontotemporal lobar degeneration with ubiquitin-only pathology and additional motor neuron damage; NCIs, neuronal cytoplasmic inclusions; NNIs, neuronal nuclear inclusions; NTs, neurites.
Copyright @ 200 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited. 8 a highly concentrated nuclear factor of still unknown function. Therefore, the protein is found not only in pathologic inclusions in FTLD-U but also in various degrees in the nuclei. Punctate nuclear labeling might interfere with the visualization of pathologic inclusions particularly during the early stage of the disease. Other published studies have also claimed that TDP-43-IR pathologic lesions can be found in other neurodegenerative disorders, including Alzheimer disease (AD) and Lewy body disease (LBD) (47Y49). Previously, the most common diagnostic tool of FTLD-U has been the IHC detection of Ubq protein in pathologic structures. Recently, however, it has been demonstrated that the detection of Ubq-IR lesions is capricious. Improvements in the Ubq-IHC procedures have meant that many subjects previously diagnosed as dementia lacking distinctive histopathology have been rediagnosed as having FTLD-U (50). The Ubq-binding protein 62/sequestosome 1 is a cytosolic 62-kd protein (51) that, like Ubq, has been shown to be a common component of NCIs, NNIs, and/or glial inclusions in several neurodegenerative diseases, including FTLD (49, 52Y65). Importantly, p62-IR is present at a very early stage of inclusion formation. Because it exhibits a high staining intensity of the inclusions with optimal contrast toward the background, it permits a reliable evaluation of pathologic lesions (49, 54) .
Here, we describe the morphologic features and anatomic distribution of neuropathologic lesions in FTLD-U subjects using immunohistochemistry for ubiquitin-binding protein p62 (p62-IHC) and compare the labeling of inclusions when using Ubq-, p62-, and TDP-43-IHC.
MATERIALS AND METHODS

Case Selection
Twenty-two cases from the Kuopio University Hospital collection fulfilled initial histologic selection criteria. In samples from the frontal cortex, there were Ubq-and p62-positive but HPT-and >S-negative inclusions ( Fig. 1 ; Table 1) . At gross examination, the brains displayed moderate to severe atrophy of the frontotemporal lobes, and there was a varying degree of superficial spongiosis and neuronal loss affecting predominantly layer II of the frontal cortex. Neuronal loss in the hypoglossal nucleus and degeneration of corticospinal tracts were also noted in 2 cases (Cases 5 and 14) (Table 1 ). Based on current criteria, 20 cases were classified as FTLD-U and 2 cases as FTLD-U/MND. There is no genotype information available on these subjects at present. Additionally, the brains of 5 control subjects within the same age range but without neurologic or neuropathologic disease were analyzed ( Table 1) . Four of the patients had myocardial infarction, and the oldest subject died of an infectious disease. The research protocol was approved by the ethical committee of the University of Kuopio.
Brain Samples
According to the standardized dissection protocol used in the Kuopio University Hospital, the brains were fixed with 10% buffered formalin by in situ perfusion via the carotid artery for 1 hour and then removed, weighed, and immersed in the same fixative for at least 1 week. After fixation, the brains were examined grossly, cut into 1-cm-thick coronal slices, and examined for macroscopically detectable lesions and vessel abnormalities. From these slices, 15 standard representative tissue blocks were cut to include cortical, subcortical, and subtentorial structures, as shown in Figure 2 . The blocks were fixed in 10% buffered formalin for an additional week, dehydrated in a graded series of alcohol, cleared in xylene, embedded in paraffin, and cut into 7-Kmthick sections.
Immunohistochemistry
The reagents were initially titrated to achieve optimal IHC stainings. The testing was carried out on 7-Km-thick tissue microarray sections, including 2-mm core samples with FTLD-U-, AD-, and LBD-related pathology and agematched control samples as described previously (49, 66) . The antibodies, dilutions, and pretreatments for IHC are described in Table 2 . For the study, deparaffinized 7-Kmthick tissue sections were manually immunostained with antibodies directed to Ubq, p62, TDP-43, >-internexin, HPT, >S, and A-amyloid (AA). All primary antibodies were incubated overnight with the exception of polyclonal TDP-43, which was incubated only for 1.5 hours at room temperature. For detection, the labeled streptavidin-biotin method (Histostain-Plus kit; Zymed, San Francisco, CA) was used with Romulin 3-amino-9-ethylcarbazole chromogen (Biocare Medical, Walnut Creek, CA). The sections were counterstained with Harris hematoxylin (Merck, Darmstadt, Germany), dehydrated, and mounted in DePex (BDH Laboratory Supplies, Poole, UK). Negative control staining with omission of primary antibodies revealed no detectable staining.
Hyperphosphorylated-T protein-, AA-, and >S-IR pathologies were assessed by applying the stains to the anatomic regions as shown in Figure 1 . In the control cases, Ubq-and p62-IHC was carried out on the temporal cortex, hippocampus, striatum, thalamus, midbrain, medulla, dentate nucleus, and cerebellar cortex, and TDP-43/IHC was performed on the temporal cortex, hippocampus, and cerebellar cortex.
All sampled sections of FTD brains were examined for p62-IR (Fig. 2) . Ubiquitin-IHC was performed on the frontal cortex, hippocampus, and on the cerebellum, >-internexin-IHC was carried out on the hippocampal sections, and TDP-43-IHC was performed on the frontal cortex in all cases. In addition, TDP-43-IHC was examined in the cerebellum when p62-labeled lesions were seen.
Assessment of Immunohistochemistry
The assessment of control and diseased samples was performed under light microscopy at 100Â to 200Â magnifications. Cellular or neuritic HPT-and >S-IR structures were sought, and when possible, the lesions were staged according to the recommendations of Braak et al (67, 68) . In AA-IHC, diffuse and dense plaques and cerebral amyloid angiopathy were assessed. In Ubq-and >-internexinYIHC, IR lesions were sought.
The sections of frontal cortex stained with the polyclonal TDP-43 antibody were assessed to classify all Copyright @ 200 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited. 8 cases as recently recommended by Cairns et al (28) and Sampathu et al (45) . Two examiners assessed the sections in 2 sittings several months apart, but it became clear that the proposed criteria for classification regarding extent and distribution of lesions were not always applicable. Thus, minor modifications were carried out. In histopathologic Type 1 cases, disregarding distribution and extent, long neurites were observed; in Type 2 cases, inclusions were primarily detected, but scattered neurites were seen when sought; and in Type 3, both thin and short neurites and inclusions were noted in the same visual field. The distribution of lesions in cortical sections was rather patchy, and in some cases, lesions had to be sought. The morphologic appearances of inclusions did not influence the classification. The distribution and severity of p62-IR lesions were determined in a semiquantitative manner using a 4-point scale: j, absent; È, occasional, but have to be sought out; +, some; and ++, moderate to frequent inclusions. For circumscribed structures (i.e. basal forebrain, substantia nigra, subthalamic nucleus, and for brainstem nuclei) the scale was j, absent; þ, some; þþ, moderate to frequent inclusions. Finally, a 4-point scale (j, no; È, occasional, but have to be sought out; 1, some; and 2, moderate to frequent) was used for rating the prevalence of p62-IR neurites.
Digital images were taken using an Olympus BX40 microscope equipped with an Olympus DP50 microscope digital camera system (Olympus Optical Co., Ltd., Tokyo, Japan).
RESULTS
The demographics of the 27 investigated subjects are shown in Table 1 . The age of the 22 neurologically impaired subjects ranged from 47 to 93 years (mean, 67 T 11 years), and there were 14 women and 8 men. The mean brain weight was 1,109 T 214 g, and the postmortem delay ranged from 3 to 144 hours. The most common cause of death was infection (13/22) , followed by complications related to cardiovascular disease (7/22) . In the 5 nondemented control 
IR Structures in Neurologically Unimpaired Controls
In the nondemented control brains, both Ubq-IR and p62-IR structures were seen ( Fig. 3 ; Table 3 ). In both supratentorial and infratentorial gray matter, the most common p62-IR profiles were spherical, granular structures of various sizes ranging from hardly notable dot-like points to structures that were the size of a glial nucleus floating in the neuropil. These structures were more numerous with Ubq when compared with p62 staining (Fig. 3A , B, D, E) and more prevalent in the cortex and hippocampus when compared with the striatum and thalamus. Many Ubq-IR, but only a few p62-IR small dots, were also seen in the white matter, particularly in the cortical and hippocampal regions. In the inferior olivary nucleus of all control subjects, there were many Ubq-and p62-IR coarse, chunky neuronal cytoplasmic aggregates (Fig. 3C, F ). In addition, both Ubqand p62-IHC revealed variable numbers of Marinesco bodies in the nuclei of neurons in the substantia nigra (Fig. 3G, H) . No Ubq-or p62-IR inclusions were seen in the cerebellum. Some HPT-, Ubq-, and p62-IR inclusions were seen in the pyramidal cells in the hippocampus (i.e. pretangles), and a few cytoplasmic skein-like structures were observed in the substantia nigra in the 2 oldest subjects (Fig. 3I, J) . Furthermore, in the hippocampus and substantia nigra, HPT-, Ubq-, and p62-IR neurites were seen (Fig. 3K ). In none of the subjects did the amount or distribution of these HPT-IR structures fulfill the criteria of any of the known tauopathies. No >S-IR pathology was seen in any of the sections. TAR-DNA-binding protein 43 labeled neuronal nuclei in punctate manner in all control cases with various intensities. No TDP-43-IR inclusions, neurites, or white matter dots were noted in any of the assessed anatomic regions.
IR Structures in Neurologically Impaired Subjects
Assessment of Age-Related Lesions and Concomitant Pathology
With respect to age-related changes, similar Ubq-IR structures were seen in all impaired subjects as were detected in unimpaired subjects. Of 22 neurologically impaired subjects, 8 (36%) had no detectable HPT-IR in any of the assessed brain regions (Cases 1, 3, 4, 5, 11, 16, 19, and 21; age range, 47Y76 years; mean age, 61 T 11 years; Table 1 ). In Copyright @ 200 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited. 8 9 (41%) subjects, HPT immunoreactivity displayed an ADrelated distribution of neurofibrillary pathology and fulfilled the criteria for Braak stages 1 to 2 (Cases 2, 6, 7, 9, 12Y15, 17, 18, 20, and 22; age range, 66Y93 years; mean age, 74 T 10 years) (68). In 5 subjects (Cases 2, 6, 7, 8, and 10; age range, 57Y73 years; mean age, 63 T 7 years), a systematic assessment revealed occasional HPT-IR structures. In 3 of these subjects (Cases 2, 6, and 10), occasional HPT-IR delicate, diffuse NCIs/neurites were seen in the temporal cortex, hippocampus, entorhinal cortex, basal nucleus of Meynert, and in the amygdaloid complex. In 2 cases (Cases 7 and 8), these structures were confined mainly to the CA2 region of hippocampal formation. In 8 of 22 subjects (36%), AA-IR aggregates were seen in the parietal and/or occipital cortices (Table 1 ). In 3 (Cases 4, 13, and 22) of these subjects, a few AA-IR dense plaques were noted, and in 1 subject (Patient 15), moderate numbers of dense plaques were seen. Diffuse plaque-like structures were detected in 3 subjects (Cases 1, 2, and 11), whereas 2 subjects (Cases 4 and 17) exhibited cerebral amyloid angiopathy. Occasional >S-IR structures were detected in 4 subjects (18%; Table 1 
Classification of FTLD-U Subjects Using TDP-43-IHC
Of 22 subject with p62-and Ubq-IR lesions in the frontal cortex, 20 also displayed TDP-43-IR lesions (Tables 4  and 5 ). Of these, 18 cases were classified according to the histologic classification scheme of Cairns et al (28) and Sampathu et al (45) . Of 18 subjects, 13 (72%) displayed both inclusions and thin, short neurites predominantly in the superficial layer; thus, they were of Type 3. In 3 of these 18 subjects (17%), primarily NCIs were seen (Type 2), and in the remaining 2 (11%) cases, thick, long neurites were the characteristic feature (Type 1). In 2 (Cases 19 and 20) of 20 subjects, only a few TDP-43-IR lesions were seen after a systematic assessment of the entire slide. Thus, even if they were TDP-43 positive, these cases remained unclassified (Table 6 ). In the remaining 2 cases, no TDP-43 pathology was seen (Cases 21 and 22; Table 6 ).
Comparison of FTLD-U Frontal Cortex Lesion Labeling Using TDP-43-, p62-, and Ubq-IHC
In most of the cases, NCIs, NNIs, and neurites were labeled with Ubq, p62, and TDP-43 (Fig. 4) . The intensity of the labeling and the contrast were excellent using the p62 antibody; the lesions were discernible using TDP-43; the poorest results were obtained when using Ubq. A significant advantage when comparing p62-with TDP-43-IHC was that the former labeled mostly pathologic lesions. When using TDP-43-IHC, various degrees of punctate nuclear labeling were seen, and particularly in those cases where there were few lesions, this did interfere with the visualization of the inclusions. Thus, unlike TDP-43-IHC, p62-IHC facilitated screening of a slide even at moderate magnification (100Â), particularly when assessing NCIs. In the cases where TDP-43-IR lesions were seen to a sufficient degree to permit a histopathologic classification (18 cases), more p62-IR lesions were seen than with the TDP-43 or Ubq stains. In the 2 cases in which there were only a few TDP-43-IR lesions (Cases 19 and 20), more extensive abnormalities were noted when using either Ubq or p62; the abnormalities were primarily NCIs. One of the remaining 2 cases lacking any TDP-43 pathology had Ubq-and p62-IR NCIs (Case 21); the other case had only Ubq-and p62-IR NNIs (Case 22). Copyright @ 200 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited. 8
p62-IR Structures in Neurologically Impaired Subjects
In general, p62-IHC revealed a plethora of IR structures, including NCIs or NNIs (Fig. 5AYP ) and glial inclusions (oligodendroglia and astrocytes; not shown). The NCIs were more frequent when compared with NNIs. The morphology of both NCIs and NNIs varied extensively, and a variety of morphologic inclusions were found in small or large neurons. In addition, different kinds of p62-IR neurites were seen, ranging in shape from short to long and from thin to thick (Fig. 5Q, R) . Occasionally, even neuritic spines or axonal sprouting were detected. Other p62-IR structures included various kinds and sizes of extrasomal deposits in the neuropil (Fig. 5S, T) . Details regarding the type and distribution of NCIs, NNIs, and neurites in each subject are given in Tables 4 to 6 .
Neuronal Cytoplasmic Inclusions
The small to medium-sized neurons typically had either granular or dense inclusions (Fig. 5) . These NCIs were mainly small, but even large structures could be found, and these had spherical (Pick body-like), oval, or crescent forms, although occasionally, even circular NCIs were observed. These kinds of inclusions were most commonly found in the neocortex (Fig. 5AYC) , particularly in the superficial layers, in the granular cell layer of the dentate gyrus (Fig. 5D, E) , amygdaloid complex, striatum, hypothalamus, and in the granular (Fig. 5F ) and molecular layers of the cerebellar cortex (Tables 4Y6). In some large neurons, NCIs were seen as a rather irregular, coarse accumulation of p62-IR (Fig. 5G, H) . These inclusions were mainly restricted to the large pyramidal neurons in the cortex, CA4 to CA1 regions of the hippocampal formation, subiculum, and in the entorhinal cortex (Tables 4Y6) . Furthermore, they were seen in the large neurons of the amygdaloid complex, thalamus, dentate nucleus, and in the cerebellar Purkinje cells. In brainstem structures, the most characteristic type of inclusions in large neurons were skein-like NCIs that appeared either as thin or thick threads (Fig. 5I) or as an aggregation of these filaments creating a coil-like structure (Fig. 5J) . Occasionally, these skein-like NCIs were also seen in large cortical neurons, including Betz cells in the motor cortex (Fig. 5K ) and in neurons of the central gray matter. Furthermore, large neurons occasionally contained rounded spherical NCIs (Fig. 5L ). These types of inclusions were numerous in the brainstem nuclei and in the deep cortical layers, amygdaloid complex, and in the thalamus. Finally, very thin filamentous p62-IR threads sometimes intertwined into a netlike structure around the nuclei of either small or large neurons, in particular in the neocortex, hippocampus, and in the basal FIGURE 3. Characteristic staining patterns of ubiquitin (Ubq) and p62-immunoreactive (IR) structures in aged-matched neurologically unimpaired control subjects. Ubiquitin antibody labels numerous small dot-like granular structures in the neuropil in both gray matter (A) and white matter (B); there are more of them when compared with p62-immunohistochemistry (D, E). Ubiquitin-IR (C) and p62-IR (F) aggregates in the large neurons of the inferior olivary nucleus. In the substantia nigra, p62-IR Marinesco bodies (G, H), as well as p62-IR inclusions in pigmented neurons (I, J), and long neurites (K) were seen. Corpora amylacea (L) and round neuropil deposits of various sizes were labeled with p62 more intensively (M, N) than with Ubq (O). Scale bar = 10 Km.
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Thin, straight filaments j j j j j j j j j j j j j j j j j j j j j j j j j j j j forebrain (Fig. 5M ). In addition, some chromatolytic neurons contained p62-IR pleomorphic aggregates (Fig. 5N ).
Neuronal Nuclear Inclusions
The rod-shaped (Bcat's eye[) inclusions were typically found in the nucleus of small to medium-sized neurons (Fig. 5O ). They were readily detected in the striatum and occasionally observed in the frontal, temporal, motor, or insular cortices. Large neurons, in turn, occasionally contained roundish, dense NNIs having a size of a nucleolus (Fig. 5P) . These NNIs were found in the neocortex, hippocampus, amygdaloid complex, striatum, thalamus, and in the Purkinje cells of the cerebellar cortex. Additionally, quite often, a round, tiny p62-IR dot in the nuclei of cortical neurons or glial cells was seen. As in the control subjects, p62-IR Marinesco bodies were often found in the nuclei of neurons in the substantia nigra.
Regional Distribution of p62 Labeling
As seen in Tables 4 to 6 , almost all neuroanatomic regions were affected to varying extents in all subjects, and this was independent of the histopathologic type. Every subject had at least some NCIs in the frontal, temporal, and parietal cortices, in the gyrus cinguli, dentate gyrus, amygdaloid complex, substantia nigra, and in the inferior olivary nucleus, whereas NCIs were rather infrequent in the cerebellar cortex, hypoglossal nucleus, dorsal motor nucleus of vagus, and in the pallidum. Numerous p62-IR neurites were most often found in the neocortex but only in approximately 40% of the subjects. In contrast, few to occasional p62-IR neurites were seen in most of the subjects in the basal forebrain, thalamus, brainstem, and the cerebellum. In addition, in 5 of our 22 subjects, numerous p62-IR neurites were seen in the pyramidal tract, which was examined at the levels of the posterior limb of the internal capsule and at the level of medulla.
Histopathologic Type 1
In 2 cases (Cases 1 and 2), the characteristic feature of the pathology seen in the neocortex when using p62-IHC was the presence of neurites that were variable in length and shape, and some had spines (Fig. 5Q) . These neurites were seen to the same extent as when using TDP-43-IHC. In addition, cross-sectioned p62-IR neurites seen as dots in the neuropil were frequently noted (Fig. 5S) . Topography of pathology, however, differed between these 2 cases (Table 4) . In Case 2, the pathology was widespread, and frequent p62-IR neurites were seen in the neocortex, entorhinal cortex, amygdaloid complex, striatum, and in the claustrum. Although p62-IHC labeled only occasional large NCIs in cortical neurons, compact p62-IR NCIs were frequent and easily recognizable in the dentate gyrus. In addition, there were only occasional skein-like NCIs in the CA2-1 regions of the hippocampal formation. Furthermore, in the amygdaloid complex and in the nucleus hypothalamus, there were netlike NCIs (Fig. 5M) , and in the hypoglossal nucleus and in the dorsal motor nucleus of vagus, NCIs were only small dots in the cytoplasm. Furthermore, the white matter, including corticospinal tracts, contained many p62-IR neurites but also inclusions in glial cells (not shown). An additional characteristic finding of Case 2 was p62-IR but TDP-43-negative NNIs approximately the size of a nucleolus (Fig. 5P ) that were seen in the large neurons in the occipital and insular cortices, in the CA1-4 regions of the hippocampal formation, in the entorhinal cortex, thalamus, and dentate nucleus, and in the Purkinje cells of the cerebellar cortex. In Case 1, the abnormalities were mainly restricted to the neocortex and to the hippocampal sections; no abnormalities were seen in the white matter, and no NNIs were observed. It is also noteworthy that in this case, concomitant >S lesions were seen in the amygdaloid complex and in the basal nucleus of Meynert.
Histopathologic Type 2
In all 3 cases of Type 2 (Cases 3Y5), more p62-IR NCIs than neurites were seen in the neocortex. In all 3 cases, there were more neurites in the neocortex when p62-IHC was used when compared with TDP-43-IHC. Throughout the analyzed regions, NCIs predominated, and there were regions where no neurites were seen (Table 4 ). Some differences in the distributional pattern of p62-IR pathology in these 3 cases were discernible. In Case 5, there were many coarse NCIs in large pyramidal neurons (Fig. 5G ) in the neocortex, CA1-4 regions of the hippocampal formation, subiculum, entorhinal cortex, amygdaloid complex, dentate nucleus, and in the cerebellar Purkinje cells. In addition, small round compact NCIs were seen, particularly in the neocortex (Fig. 5A) . Furthermore, some netlike NCIs (Fig. 5M) were widely distributed. In addition, neuronal loss and skein-like NCIs were seen in the hypoglossal nucleus. Two of the cases (Cases 3 and 4) did not display any p62-IR pathology in the cerebellar cortex. Furthermore, only some of the detected inclusions were compact, circular NCIs (Fig. 5C ), whereas most of them were netlike (Fig. 5M) . One of these cases (Case 4) also displayed skein-like NCIs in the hypoglossal nucleus.
Histopathologic Type 3
In 13 cases, the characteristic p62-IR feature in the neocortex was the nearly equal density of NCIs and neurites ( Table 5 ). The extent of these lesions seemed to be higher with p62 when compared with TDP-43YIHC. In most subjects, the neurites were very thin and short.
Seven of these subjects (Cases 6, 10Y12, and 14Y16) had coarse NCIs in large pyramidal neurons (Fig. 5G) in the cortex, CA1-4 regions of the hippocampal formation, subiculum, entorhinal cortex, amygdaloid complex, thalamus, dentate nucleus, and in the cerebellar Purkinje cells (Table 5 ). In addition, these subjects had small, compact NCIs in the neocortex (Fig. 5A ) and in the granular cells of the cerebellar cortex (Fig. 5F ). In 5 of these 7 subjects, skein-like NCIs were seen in the hypoglossal nucleus.
One subject (Case 13), however, had only dot-like structures in large pyramidal neurons in all regions listed above, and no compact NCIs in the granule cells of the cerebellar cortex were noted.
In 4 subjects (Cases 8, 9, 17, and 18), the p62-IR inclusions in the neocortex were round (Fig. 5A ), crescent Copyright @ 200 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited. 8 
Copyright @ 200 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited. 8
( Fig. 5C ), or netlike NCIs in small or large neurons (Fig. 5M ).
In the other analyzed brain regions, the netlike NCIs predominated. In 3 of these cases (Cases 8, 17, and 18), no cerebellar abnormalities were seen, whereas in Case 9, occasional round, compact NCIs were seen in the dentate nucleus. In Cases 17 and 18, neocortical pathology was most severe in the frontal and temporal cortices, whereas in Cases 8 and 9, the neocortical pathology was most prominent in the parietal and motor cortices. In one of these cases (Case 9), numerous skein-like NCIs were seen in the hypoglossal nucleus.
In the last subject (Case 7), darkly stained thick, quite short, and curvilinear neurites were seen, particularly in the parietal, motor, and insular cortices in both white and gray matter (Fig. 5R ). This neuritic pathology was the most dominant feature in these regions. Furthermore, no long, thick neurites, as those seen in histologic Type 1 described by Cairns et al (28) , were noted. In addition, cross-sectioned p62-IR neurites seen as dots in the neuropil were often observed (Fig. 5S) . Some of the detected NCIs were crescent shaped (Fig. 5C ), whereas many neurons had netlike or skein-like NCIs (Fig. 5M) . In this case (Case 7), many of the 
Unclassified Cases
In 2 subjects (Cases 19 and 20), the extent of TDP-43-IR pathology was not sufficient to permit classification. These cases had very prominent and widespread p62-IR pathology, including coarse NCIs in large pyramidal neurons (Fig. 5G) in the cortex, CA1-4 regions of the hippocampal formation, subiculum, entorhinal cortex, amygdaloid complex, thalamus, dentate nucleus, and in the cerebellar Purkinje cells. In addition, small, compact NCIs in cerebellar granular cells (Fig. 5F ) were occasionally detected in 1 of these cases (Case 19), and in 1 case (Case 20), they were frequent. Although both cases also displayed some neuritic pathology, the NCIs predominated in most of the analyzed brain regions.
In the last 2 subjects (Cases 21 and 22), no TDP-43-IR lesions were seen in the section of frontal cortex. In Case 21, large p62-IR NCIs that had oval, round, crescent, or sometimes even circular shapes (Fig. 5B) were seen in small and large neurons, including Betz cells. These NCIs were variably stained with Ubq and were >-internexin negative. These inclusions were faintly stained when using the monoclonal anti-TDP-43 antibody but lacked any IR with the polyclonal TDP-43 antibody. In general, NCIs predominated, and IR neurites were rare, with the exception of a few regions such as the CA1 region of the hippocampal formation, the subiculum, entorhinal cortex, and the caudate nucleus, where neurites predominated. Furthermore, the cortical white matter contained neurites and glial inclusions, and skein-like NCIs were seen in the hypoglossal nucleus. The main characteristic feature of Case 22 was p62-and Ubq-IR NNIs of the size of a nucleolus (Fig. 5P ) that were seen in the large neurons. These NNIs were readily detected in the thalamus and in the CA1-4 regions of the hippocampal formation but were also detected in the neocortex, amygdaloid complex, striatum, claustrum, and in the Purkinje cells of the cerebellar cortex. The dentate gyrus contained only occasional granular NCIs (Fig. 5D) , and in the hypoglossal nucleus, skein-like NCIs were seen. In this case, concomitant HPT and >S pathology was seen.
DISCUSSION
TAR-DNA-binding protein 43 is reported to be a common pathologic substrate underlying a large subset of FTLD-U disorders, and thus, TDP-43-IHC has been recommended for diagnosis (29) . In 2006, histopathologic classification of FTLD-U cases into 3 types was recommended by Sampathu et al (45) , and recently, this classification was applied when categorizing 193 subjects using the commercial TDP-43 antibody (28) . Thus, we also classified our cases using TDP-43-IHC following these recommendations. It should be noted, however, that to be able to classify the cases as recommended, we had to ignore the extent (abundant, numerous) of lesions and instead emphasized the type (NCIs vs neurites) and predominance of the lesions. The reason for this minor modification was the uneven and patchy distribution of IR lesions that made the assessment of the overall extent of immunoreactivity unreliable. Of the 20 FTLD-U and 2 FTLD-U/MND cases studied, 18 were classified as recommended (28) . Seventy-two percent were of Type 3, 17% were of Type 2, and 11% were of Type 1. This distribution is similar to the type distribution in the report by Cairns et al (28) (53% of Type 3, 30% of Type 2, and 18% of Type 1). In addition, 4 of our cases (18%) lacked a sufficient amount of TDP-43-IR and, consequently, were not classifiable as recommended.
One of our goals was to test the usefulness of IHC for Ubq-binding protein p62/sequestosome 1 in the visualization of the inclusions that are seen in FTLD-U. Indeed, p62-IHC labeled numerous lesions intensely and with good contrast. p62 protein is not a specific marker, however, because it has been shown to be a common component of NCIs, NNIs, and/or glial inclusions in several neurodegenerative diseases (49, 52Y65).
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Some previous studies have successfully used p62-IHC in FTLD-U cases (49, 55, 57, 61, 64, 65) . Furthermore, in a recent methodologic study, the use of p62 immunodetection was recommended as a diagnostic screening stain for assessment of degenerative dementias, including FTLD-U cases (49) .
In most prior studies, the assessment of lesions in FTLD-U and/or FTLD-U/MND cases has been restricted to the hippocampus, neocortex, striatum, substantia nigra, and the inferior olivary nucleus (1Y4, 13Y15, 18, 28, 37Y45 ). In 2005, however, Mackenzie and Feldman (46) assessed numerous brain regions and described the regional distribution of Ubq-IR pathology in 30 FTLD-U (MND-d) cases, with 15 of them being defined as FTLD-U/MND. Although pathologic alterations were widespread, they reported that some regions (e.g. the subthalamic nucleus, hypothalamus, locus coeruleus, cranial nerve nuclei, pontine nuclei, inferior olivary nucleus, cerebellar cortex, and the dentate nucleus) were virtually unaffected (46) . By contrast, in the present H) ; second, skein-like inclusions (I), skein-like filaments intertwined into a coil-like structure (J), or skein-like inclusions in a Betz cell in the motor cortex (K); and third, more infrequent rounded spherical inclusions (L). In addition to clear inclusions, very thin filamentous threads intertwined into a netlike structure around the nuclei (M). Occasionally, chromatolytic neurons with p62-IR pleomorphic aggregates were seen (N). Neuronal nuclear inclusions were either rod-shaped (''cat's eye'') in the nucleolus of small to medium-sized neurons (O), or occasionally, they were somewhat round, dense inclusions having the size of a nucleolus (P). The sizes and shapes of the p62-IR neurites ranged from short to long and thin to thick; some neuritic spines were detected (Q, R). Additional p62-IR structures included several kinds of extrasomal neuropil deposits of varying sizes, including cross-sectioned p62-IR neurites seen as neuropil dots (S) or spheroids (T).
8 study using p62-IHC and systematically assessing the brain, lesions were seen in FTLD-U cases in most of the previously listed regions, although they were absent in controls. Furthermore, we also observed a wide range of variability in both the morphology and distribution of pathology within each of the recently defined histopathologic types (28) . In line with this, Cairns et al already noted that despite the common pathologic substrate of TDP-43 protein, there is a significant clinical, genetic, and neuropathologic heterogeneity within the FTLD-U types (28) . With respect to histopathologic Type 1, there were 2 subjects with similar pathology in the frontal cortex. However, the distribution of p62-IR pathology varied because it was more widespread in 1 of these subjects. Similarly, with respect to histopathologic Type 2, there were 3 subjects with similar pathology in the frontal cortex by TDP-43-IHC, but using p62-IHC, NCIs predominated not only in the frontal cortex but also in all the other regions in all 3 cases. Involvement of the cerebellum, however, was seen in only 1 of the 3 cases. The 13 cases that fulfilled the histopathologic Type 3 criteria were more heterogeneous with respect to both morphology and distribution of lesions. In the distributional pattern, 2 separate groups were identified: those without (n = 5) and those with (n = 8) cerebellar involvement. Furthermore, in almost all (11/13) cases, Bcat-eye[ NNIs were seen either in the striatum or in the neocortex. In the hypoglossal nucleus, skein-like p62-IR NCIs were seen in the 2 FTLD-U/MND cases and in 50% of FTLD-U subjects who lacked any clinical signs of motor neuron involvement. In line with this, Dickson et al (69) recently reported that in 12% of their FTLD-U cases, sparse TDP-43-IR NCIs were detected in motor neurons. Our study revealed a large number of cases with p62-IR pathology in the hypoglossal nucleus, and, thus, it is tempting to speculate that a considerable number of FTLD-U cases might evolve into FTLD-U/MND. The most notable variability in our 18 histopathologically classified cases (28) was the diversity in the topography of the pathology. This might be due to the likelihood that not all of our cases were at the same stage in the progression of their disease. This interpretation would be consistent with the situation seen in AD and in LBD in which systematic assessment of numerous cases has revealed that the HPT pathology in AD (68) and >S pathology in LBD (67) seems to progress in a predictable manner from 1 region to another. Because of the limited number of cases, it is currently impossible to provide any proposals for a possible staging system for FTLD-U. Furthermore, the significant variability that was seen particularly in the cerebellum might be attributable to modifying genes and/or risk factors. Similar modification of pathology has been reported to be found in AD cases with presenilin 1 mutation that display early unpredicted aggregation of AA in the striatum (70) . Indeed, a risk factor, the apolipoprotein E ?4 allele, has been reported to modify the extent of AA pathology in AD (71) . It should also be emphasized that concomitant HPT and >S pathology in FTLD-U subjects might also influence the topographic distribution of TDP-43 lesions (47, 48) . For example, in a recent report by Higashi et al, it was reported that when TDP-43 pathology was seen in association with AD and LBD pathology, the distribution varied when compared with pure FTLD-U cases (47) .
In FTLD-U, Ubq-and/or TDP-43-IR structures have highly variable morphologies and localizations. They have been described as dense, granular or filamentous, round, oval, crescent or circular/annular, located in the cytoplasm of small/medium/large neurons, lentiform or rod-shaped in nuclei, as inclusions in glia, and short/twisted/tortuous/curvilinear neurites (1, 27, 28, 37Y46) . We also found a plethora of p62-IR structures; the morphologic features of these structures were readily discernible.
The variable morphologic features of NCIs in FTLD-U might reflect the morphogenesis of NCIs, that is, at an early stage, a netlike aggregate is seen, whereas in the later stages, coarse aggregates dominate. This would be consistent with the variable morphologic spectrum of NCIs seen in LBD, as has been previously described by Kuusisto et al (54) . A recent hypothesis, however, challenges this interpretation, suggesting that other factors such as human silent information regulator 2 NAD+-dependent protein deacetylase (SIRT2) might influence not only the morphology (i.e. 1 large or many small inclusions) but also the significance (i.e. disease related or disease unrelated), of the >S inclusions (72) . Whether similar associations are to be found in FTLD-U needs to be investigated. Another possible cause of the variable morphologies of NCIs in FTLD-U is that they are located in different cell types. Similarly, HPT-containing inclusions in AD in the pyramidal cells of the hippocampus are commonly flame-shaped, whereas in large neurons (e.g. those in the nucleus basalis of Meynert), they are rather globular. Furthermore, when HPT inclusions are seen in glial cells (e.g. in progressive supranuclear palsy or in corticobasal degeneration), the morphologies of inclusions are highly variable (73) . Thus, the variable morphology of NCIs in FTLD-U might indicate either that there is a spectrum of the same disease or that there are different diseases; this requires further detailed assessment.
Consistent with previous studies (39, 41Y43, 45, 46, 74Y77), some of our subjects (50%), all being of histopathologic Type 3, had rod-shaped (Bcat's eye[) NNIs in small to medium-sized neurons. The NNIs have most often been seen in familial cases (39, 42, 43, 46, 74Y76) but sometimes also in sporadic cases (41, 45, 77) . Recently, Mackenzie et al (42) linked NNIs with numerous NCIs and neurites and with the mutation in the progranulin gene. Our data are in line with this because most of our cases with NCIs and neurites (i.e. histopathologic Type 3) also displayed NNIs (85%). Unfortunately, no genetic assessment on most of our cases can be carried out due to the lack of suitable samples for DNA analysis.
In 2 of our cases with substantial p62-IR NCIs and some neurites in the frontal cortex, only a few TDP-43-IR NCIs were noted. Consequently, these cases remained unclassified. The extent of p62-IR pathology was abundant in these cases, and thus, it is not likely they represent early stages of any of the previously described types of FTLD-U. Cairns et al (28) stated that in subjects with TDP-43-negative but Ubq-positive inclusions in the frontal cortex, the diagnosis is most likely FTLD with charged multivesicular body protein Copyright @ 200 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited. 8 2B mutation, that is, FTD linked to chromosome 3. In their cases, the Ubq-IR inclusions were described as granular, and no neurites were observed. In both of our cases, primarily coarse p62-IR NCIs predominated, but, in addition, some neurites were seen. Interestingly, in both of our cases, pathologic lesions were extensive and widely distributed, including in the cerebellum. In a recent report, neuropathologic lesions were assessed in 4 members of a family with FTD linked to chromosome 3 (64) , and in all subjects, a variable number (numerous to rare) of TDP-43-negative but Ubq-and p62-IR NCIs were seen, whereas neurites were rare. Because the Ubq-and p62-IHC are not fully comparable (49) and it has been previously reported that p62 is incorporated into the inclusion before Ubq (54), our 2 cases might represent FTLD with the charged multivesicular body protein 2B mutation. However, a detailed comparison of the pathology is not possible primarily due to methodological differences (IHC and regions assessed) in these studies. Two of our cases lacked any detectable polyclonal TDP-43-IR. In 1 of these subjects, there were widely distributed large p62-and Ubq-positive but >-internexinnegative inclusions. This case resembles the cases with basophilic inclusions described by Josephs et al (78) and by Ishihara et al (79) . These basophilic inclusions have been reported as being either Ubq positive or Ubq negative. These differing results in labeling might once again be due to methodological aspects. However, using p62-IHC, the inclusions were well labeled, numerous, and widely distributed.
In the second subject lacking any detectable polyclonal TDP43-IR, p62-IR NNIs that had the size of a nucleolus were seen in large neurons in several brain regions. Similar Ubq-IR NNIs but no NCIs or neurites have been described previously in a few regions in subjects with amyotrophic lateral sclerosis (80, 81) . In contrast to the amyotrophic lateral sclerosis cases, our subject did not display any cell loss in the hypoglossal nucleus or corticospinal tract degeneration. p62-IR was, however, seen in the hypoglossal nucleus. These observations link large NNIs with NCIs in the hypoglossal nucleus and MND, but the type of linkage is still unclear. Interestingly, these p62-IR but TDP43-negative NNIs were also seen in 1 of our histopathologic Type 1 cases. This case also displayed NCIs in the hypoglossal nucleus, and numerous IR neurites were seen in corticospinal tracts. The significance of this association needs to be elucidated.
In general, we found more pathologic IR lesions using p62-IHC than TDP-43-IHC. The cerebellar p62-IR NCIs, however, were not detected when using either monoclonal or polyclonal TDP-43 antibodies and were only faintly labeled with Ubq. Consistent with these observations, Arai et al (55) described a case that exhibited Ubq-negative but p62-positive glial structures, and Parkinson et al (60) reported p62-positive and Ubq-negative glial inclusions in subjects with charged multivesicular body protein 2B mutation. Furthermore, it has been reported that TDP-43-IR glial inclusions are variably Ubq labeled (28, 82) . These findings indicate that inclusions in various cells and in different brain regions seem to contain different proteins. This might be due to the morphogenesis of inclusions, that is, TDP-43, p62, and Ubq are incorporated into the inclusions at various stages of inclusion formation. Likewise, Kuusisto et al have reported that misfolded proteins such as HPT and/or >S are first incorporated in the cytoplasm and are then followed by incorporation of p62 before Ubq (54) . Another possible explanation is primarily related to methodological aspects. The preservation of TDP-43 as well as Ubq and p62 epitopes in relation to postmortem delay and fixation has not been systematically studied. In this study, TDP43, Ubq, and p62 were detected, although the postmortem delays ranged from 3 to 144 hours. It is plausible also that methodological aspects might lead to variable labeling of different pathologic structures by different commercial antibodies, as has recently been described both with respect to p62 (49) and other proteins (83) . Similarly, Zhang et al (84) reported that more inclusions were seen with polyclonal than with monoclonal TDP-43 antibody, a finding consistent with our observations (detailed results not given).
Based on the limited number of studies using Ubq-, p62-, and TDP-43-IHC, it is too early to state whether the previous observations (i.e. the spectrum of morphology and labeling of pathologic structures) are real or merely reflect the variability in the methodology used (i.e. different antibodies and antigen retrieval methods [66, 85] ) or reflect various stages or modifications of 1 disease.
In the present study, we were able to classify almost all of our cases using the criteria proposed by Cairns et al (28) . The p62 antibody clearly proved to be an excellent label for detecting inclusions that were easily discernible, and a plethora of morphologies was identified. In line with previous reports, most of our cases were histopathologically classified when assessing the section of frontal cortex; however, when comparing TDP-43-with p62-IHC, the latter visualized more lesions and with good contrast and, in this way, simplified the classification. Moreover, 18% of FTLD-U cases lacked notable TDP-43-positive lesions but displayed p62-IR lesions. Thus, when compared with Ubq and TDP-43, p62-IHC is more reliable when searching for NCIs, NNI, and neurites, in particular, when these lesions are few in number. We noted extensive variability in the topographic distribution of pathology within histopathologic FTLD-U types. Whether these differences represent different disease entities, various stages of the same disease, or biologic modifications of the same disease is currently unclear. Larger series of cases will need to be systematically assessed to clarify these issues.
